National addiction treatment provider launches virtual-only programming in states where it has no physical presence, starting with IdahoKING OF PRUSSIA,...
BOCA RATON, Fla., June 30, 2026 /PRNewswire/ -- Dazos has launched SamurAI, an AI-native product line built on top of the...
Successful founders are increasingly discovering that the greatest barrier to growth isn't strategy—it's the person leading the business.DEERFIELD BEACH, Fla.,...
Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or...
Toronto, Ontario--(Newsfile Corp. - June 25, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or...
The First Responder Lifeline Program at Desert Hope Treatment offers first responders a confidential place to heal with separate admissions,...
From regional startup to national leader: Hansei has scaled its behavioral health RCM services to providers across 42 states.FRANKLIN, Tenn.,...
From regional startup to national leader: Hansei has scaled its behavioral health RCM services to providers across 42 states.FRANKLIN, Tenn.,...
Interim phase 1/2 data confirm significant anti-fentanyl antibody production at the lowest dose, with a well-tolerated safety profile across all...
Randomized, double-blind, placebo-controlled study to evaluate safety, tolerability, and dose-response efficacy of oral Ketamir-2 at a leading U.S. cancer center...
"As DEA Prepares for June 29 Hearing, MMJ International Holdings Brings Forward the Very Experts Who Built, Enforced, and Understand...
Integrated Solution Combines Mayo Clinic Platform-Qualified OUD Risk Prediction and Patented Opioid Tapering Behavioral Health Referral TechnologiesDENVER, June 15, 2026...
Canada's largest mental health teaching hospital unifies clinical and administrative systems with AI-powered applications suite to improve visibility, efficiency, and...
Toronto, Ontario--(Newsfile Corp. - June 12, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company") is...
Cebranopadol is an investigational, first-in-class dual-NMR agonist in development for acute and chronic pain as well as opioid use disorderFive...
Portion of Proceeds to Benefit The Matthew Perry FoundationCINCINNATI, June 10, 2026 /PRNewswire/ -- Everything But The House (EBTH) is...
CLEVELAND, June 10, 2026 (GLOBE NEWSWIRE) -- SPR® announced the publication of “Observations from the RESET Clinical Trial: A Post-Hoc...
FDA grants Orphan Drug Designation (ODD) to Tris Pharma’s TRN-257 for the treatment of idiopathic hypersomnia, based on the plausible...
Preliminary Data Analysis Reveals Over 80% Remission Rate One Year after Accelerated Deep TMS Treatment, with Decline in Severe Functional...
BPGbio Appoints Renowned Neuroscientist Eric J. Nestler, M.D., Ph.D., as Chair of Scientific Advisory Board Dr. Nestler, world-renowned neuroscientist, Dean...